Genetic Evidence for Repurposing of GLP1R (Glucagon‐Like Peptide‐1 Receptor) Agonists to Prevent Heart Failure

BACKGROUND: This study was designed to investigate the genetic evidence for repurposing of GLP1R (glucagon‐like peptide‐1 receptor) agonists to prevent heart failure (HF) and whether the potential benefit exceeds the benefit conferred by more general glycemic control. METHODS AND RESULTS: We applied...

Descripción completa

Detalles Bibliográficos
Autores principales: Daghlas, Iyas, Karhunen, Ville, Ray, Devleena, Zuber, Verena, Burgess, Stephen, Tsao, Philip S., Lynch, Julie A., Lee, Kyung Min, Voight, Benjamin F., Chang, Kyong‐Mi, Baker, Emma H., Damrauer, Scott M., Howson, Joanna M. M., Vujkovic, Marijana, Gill, Dipender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403330/
https://www.ncbi.nlm.nih.gov/pubmed/34184541
http://dx.doi.org/10.1161/JAHA.120.020331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403330/
https://www.ncbi.nlm.nih.gov/pubmed/34184541
http://dx.doi.org/10.1161/JAHA.120.020331

Ejemplares similares